Schwefel, K., Spiegler, S., Ameling, S., Much, C. D., Pilz, R. A., Otto, O., . . . Rath, M. (2018). Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening. J Cell Mol Med.
Citação norma ChicagoSchwefel, Konrad, Stefanie Spiegler, Sabine Ameling, Christiane D. Much, Robin A. Pilz, Oliver Otto, Uwe Völker, Ute Felbor, and Matthias Rath. "Biallelic CCM3 Mutations Cause a Clonogenic Survival Advantage and Endothelial Cell Stiffening." J Cell Mol Med 2018.
ציטוט MLASchwefel, Konrad, et al. "Biallelic CCM3 Mutations Cause a Clonogenic Survival Advantage and Endothelial Cell Stiffening." J Cell Mol Med 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.